Literature DB >> 29490140

Elucidating an Amorphous Form Stabilization Mechanism for Tenapanor Hydrochloride: Crystal Structure Analysis Using X-ray Diffraction, NMR Crystallography, and Molecular Modeling.

Sten O Nilsson Lill1, Cory M Widdifield2, Anna Pettersen1, Anna Svensk Ankarberg3, Maria Lindkvist3, Peter Aldred3, Sandra Gracin3, Norman Shankland4, Kenneth Shankland4,5, Staffan Schantz3, Lyndon Emsley6.   

Abstract

By the combined use of powder and single-crystal X-ray diffraction, solid-state NMR, and molecular modeling, the crystal structures of two systems containing the unusually large tenapanor drug molecule have been determined: the free form, ANHY, and a dihydrochloride salt form, 2HCl. Dynamic nuclear polarization (DNP) assisted solid-state NMR (SSNMR) crystallography investigations were found essential for the final assignment and were used to validate the crystal structure of ANHY. From a structural informatics analysis of ANHY and 2HCl, conformational ring differences in one part of the molecule were observed which influence the relative orientation of a methyl group on a ring nitrogen and thereby impact the crystallizability of the dihydrochloride salt. From quantum chemistry calculations, the dynamics between different ring conformations in tenapanor is predicted to be fast. Addition of HCl to tenapanor results in general in a mixture of protonated ring conformers and hence a statistical mix of diastereoisomers which builds up the amorphous form, a-2HCl. This was qualitatively verified by 13C CP/MAS NMR investigations of the amorphous form. Thus, to form any significant amount of the crystalline material 2HCl, which originates from the minor (i.e., energetically less stable) ring conformations, one needs to involve nitrogen deprotonation to allow exchange between the minor and major conformations of ANHY in solution. Thus, by controlling the solution pH value to well below the p Ka of ANHY, the equilibrium between ANHY and 2HCl can be controlled and by this mechanism the crystallization of 2HCl can be avoided and the amorphous form of the dichloride salt can therefore be stabilized.

Entities:  

Keywords:  X-ray diffraction; amorphous; crystal structure; density functional theory; solid-state NMR; stabilization

Mesh:

Substances:

Year:  2018        PMID: 29490140     DOI: 10.1021/acs.molpharmaceut.7b01047

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Structure determination of organic compounds by a fit to the pair distribution function from scratch without prior indexing.

Authors:  Carina Schlesinger; Stefan Habermehl; Dragica Prill
Journal:  J Appl Crystallogr       Date:  2021-05-09       Impact factor: 3.304

Review 2.  Periodic DFT Calculations-Review of Applications in the Pharmaceutical Sciences.

Authors:  Anna Helena Mazurek; Łukasz Szeleszczuk; Dariusz Maciej Pisklak
Journal:  Pharmaceutics       Date:  2020-05-01       Impact factor: 6.321

3.  Solid-State Study of the Structure, Dynamics, and Thermal Processes of Safinamide Mesylate─A New Generation Drug for the Treatment of Neurodegenerative Diseases.

Authors:  Tomasz Pawlak; Marcin Oszajca; Małgorzata Szczesio; Marek J Potrzebowski
Journal:  Mol Pharm       Date:  2021-12-02       Impact factor: 4.939

4.  De Novo Crystal Structure Determination from Machine Learned Chemical Shifts.

Authors:  Martins Balodis; Manuel Cordova; Albert Hofstetter; Graeme M Day; Lyndon Emsley
Journal:  J Am Chem Soc       Date:  2022-04-13       Impact factor: 16.383

5.  A Machine Learning Model of Chemical Shifts for Chemically and Structurally Diverse Molecular Solids.

Authors:  Manuel Cordova; Edgar A Engel; Artur Stefaniuk; Federico Paruzzo; Albert Hofstetter; Michele Ceriotti; Lyndon Emsley
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2022-09-23       Impact factor: 4.177

6.  Chemical shifts in molecular solids by machine learning.

Authors:  Federico M Paruzzo; Albert Hofstetter; Félix Musil; Sandip De; Michele Ceriotti; Lyndon Emsley
Journal:  Nat Commun       Date:  2018-10-29       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.